This video highlights patient variables, including kidney function or history of diabetes, that can help guide treatment in chronic myeloid leukemia.
In this video, Ruediger Hehlmann, MD, of the University of Heidelberg in Germany, discusses patient variables-including kidney function or history of diabetes-that can help guide treatment in chronic myeloid leukemia (CML), and reviews the need for molecular monitoring for disease relapse.
Hehlmann spoke on this topic during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations
July 30th 2025Researchers have found that donor age is a key determinant of outcomes in hematopoietic cell transplantation, with younger donors associated with significantly better survival and lower rates of GVHD.